National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
Immune Tolerance Network, Bethesda, Maryland.
Arthritis Rheumatol. 2015 Jul;67(7):1922-32. doi: 10.1002/art.39153.
To discover biomarkers involved in the pathophysiology of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and to determine whether low-density granulocytes (LDGs) contribute to gene expression signatures in AAV.
The source of clinical data and linked biologic specimens was a randomized controlled treatment trial in AAV. RNA sequencing of whole blood from patients with AAV was performed during active disease at the baseline visit and during remission 6 months later. Gene expression was compared between patients who met versus those who did not meet the primary trial outcome of clinical remission at 6 months (responders versus nonresponders). Measurement of neutrophil-related gene expression was confirmed in peripheral blood mononuclear cells (PBMCs) to validate the findings in whole blood. A negative-selection strategy isolated LDGs from PBMC fractions.
Differential expression between responders (n = 77) and nonresponders (n = 35) was detected in 2,346 transcripts at the baseline visit (P < 0.05). Unsupervised hierarchical clustering demonstrated a cluster of granulocyte-related genes, including myeloperoxidase (MPO) and proteinase 3 (PR3). A granulocyte multigene composite score was significantly higher in nonresponders than in responders (P < 0.01) and during active disease than during remission (P < 0.01). This signature strongly overlapped an LDG signature identified previously in lupus (false discovery rate by gene set enrichment analysis <0.01). Transcription of PR3 measured in PBMCs was associated with active disease and treatment response (P < 0.01). LDGs isolated from patients with AAV spontaneously formed neutrophil extracellular traps containing PR3 and MPO.
In AAV, increased expression of a granulocyte gene signature is associated with disease activity and decreased response to treatment. The source of this signature is likely LDGs, a potentially pathogenic cell type in AAV.
发现与抗中性粒细胞胞浆抗体相关性血管炎(AAV)病理生理学相关的生物标志物,并确定低密粒细胞(LDG)是否有助于 AAV 的基因表达特征。
临床数据和相关生物样本的来源是 AAV 的一项随机对照治疗试验。在基线就诊时处于活动期以及 6 个月后缓解期对 AAV 患者的全血进行 RNA 测序。比较了在 6 个月时达到主要临床试验缓解终点(应答者与未达到者)的患者之间的基因表达。为了验证全血中的发现,在外周血单核细胞(PBMC)中证实了中性粒细胞相关基因表达的测量。从 PBMC 部分中使用负选择策略分离 LDG。
在基线就诊时(P < 0.05),应答者(n = 77)和无应答者(n = 35)之间检测到 2346 个转录本之间存在差异表达。无监督层次聚类显示出一个粒细胞相关基因簇,包括髓过氧化物酶(MPO)和蛋白酶 3(PR3)。无应答者的粒细胞多基因复合评分明显高于应答者(P < 0.01),并且在活动期比缓解期更高(P < 0.01)。该特征与先前在狼疮中确定的 LDG 特征强烈重叠(基因集富集分析的错误发现率 <0.01)。PBMC 中测量的 PR3 转录与疾病活动和治疗反应相关(P < 0.01)。从 AAV 患者中分离的 LDG 自发形成含有 PR3 和 MPO 的中性粒细胞细胞外陷阱。
在 AAV 中,粒细胞基因特征的表达增加与疾病活动度和对治疗的反应降低有关。该特征的来源可能是 LDG,这是 AAV 中的一种潜在致病性细胞类型。